Literature DB >> 12799861

[Medical therapy for menstrual migraine].

V Pfaffenrath1, A Goes.   

Abstract

A menstrual migraine occurs in approximately 7-10 % of women suffering from migraine. The migraine occurs from 2 days before until 3 days after the end of the menstrual period. The choice of treatment depends on the duration of the attack, which ranges from 3 to 7 days. An attack of up to 3 days duration should be treated with acetylsalicylic acid, ergotamine tartrate or naproxen, each in combination with an antiemetic (domperidone, metoclopramide). If there is no response, sumatriptan can be administered orally (25-100 mg) or subcutaneously (6 mg). In the attacks continue for more than 3 days, short-term prophylaxis with naproxen or the application of an estrogen-containing patch is indicated. Neither ovulation inhibitors nor traditional migraine prophylaxis has an influence on menstrual migraine. Patients should keep a headache diary. Short-term prophylaxis with ergotamine tartrate or tamoxifen is obsolete.

Entities:  

Year:  1996        PMID: 12799861     DOI: 10.1007/s004829600043

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  13 in total

1.  Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration.

Authors:  B W Somerville
Journal:  Neurology       Date:  1975-03       Impact factor: 9.910

2.  Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.

Authors:  G Sances; E Martignoni; L Fioroni; F Blandini; F Facchinetti; G Nappi
Journal:  Headache       Date:  1990-11       Impact factor: 5.887

3.  Prevention of menstrual migraine by percutaneous oestradiol.

Authors:  B de Lignières; M Vincens; P Mauvais-Jarvis; J L Mas; P J Touboul; M G Bousser
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

4.  The role of estradiol withdrawal in the etiology of menstrual migraine.

Authors:  B W Somerville
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

5.  Treatment of menstrual migraine by oestradiol implants.

Authors:  A L Magos; K J Zilkha; J W Studd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

Review 6.  The role of sex hormones in headache.

Authors:  S D Silberstein
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

7.  Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test.

Authors:  M G Smits; Y G van der Meer; J P Pfeil; J J Rijnierse; A J Vos
Journal:  Headache       Date:  1994-02       Impact factor: 5.887

8.  Treatment of acute migraine with subcutaneous sumatriptan.

Authors:  R K Cady; J K Wendt; J R Kirchner; J D Sargent; J F Rothrock; H Skaggs
Journal:  JAMA       Date:  1991-06-05       Impact factor: 56.272

9.  Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.

Authors:  M P Solbach; R S Waymer
Journal:  Obstet Gynecol       Date:  1993-11       Impact factor: 7.661

10.  Migraine and reporoductive hormones throughout the menstrual cycle.

Authors:  M T Epstein; J M Hockaday; T D Hockaday
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.